Literature DB >> 16790086

Gene expression profile related to the progression of preneoplastic nodules toward hepatocellular carcinoma in rats.

Julio Isael Pérez-Carreón1, Cristina López-García, Samia Fattel-Fazenda, Evelia Arce-Popoca, Leticia Alemán-Lazarini, Sergio Hernández-García, Véronique Le Berre, Sergueï Sokol, Jean Marie Francois, Saúl Villa-Treviño.   

Abstract

In this study, we investigated the time course gene expression profile of preneoplastic nodules and hepatocellular carcinomas (HCC) to define the genes implicated in cancer progression in a resistant hepatocyte model. Tissues that included early nodules (1 month, ENT-1), persistent nodules (5 months, ENT-5), dissected HCC (12 months), and normal livers (NL) from adult rats were analyzed by cDNA arrays including 1185 rat genes. Differential genes were derived in each type of sample (n = 3) by statistical analysis. The relationship between samples was described in a Venn diagram for 290 genes. From these, 72 genes were shared between tissues with nodules and HCC. In addition, 35 genes with statistical significance only in HCC and with extreme ratios were identified. Differential expression of 11 genes was confirmed by comparative reverse transcription-polymerase chain reaction, whereas that of 2 genes was confirmed by immunohistochemistry. Members involved in cytochrome P450 and second-phase metabolism were downregulated, whereas genes involved in glutathione metabolism were upregulated, implicating a possible role of glutathione and oxidative regulation. We provide a gene expression profile related to the progression of nodules into HCC, which contributes to the understanding of liver cancer development and offers the prospect for chemoprevention strategies or early treatment of HCC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16790086      PMCID: PMC1592455          DOI: 10.1593/neo.05841

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  52 in total

1.  Molecular pathogenesis of human hepatocellular carcinoma.

Authors:  Snorri S Thorgeirsson; Joe W Grisham
Journal:  Nat Genet       Date:  2002-08       Impact factor: 38.330

2.  Oxidative stress and hepatitis C viral infection.

Authors:  Kazuhiko Koike; Hideyuki Miyoshi
Journal:  Hepatol Res       Date:  2005-12-20       Impact factor: 4.288

3.  Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6).

Authors:  Martin G Belinsky; Zhe-Sheng Chen; Irina Shchaveleva; Hao Zeng; Gary D Kruh
Journal:  Cancer Res       Date:  2002-11-01       Impact factor: 12.701

4.  Genomic sequencing.

Authors:  G M Church; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

Review 5.  Gene expression profiling of preneoplastic liver disease and liver cancer: a new era for improved early detection and treatment of these deadly diseases?

Authors:  Jin Woo Kim; Xin Wei Wang
Journal:  Carcinogenesis       Date:  2003-03       Impact factor: 4.944

Review 6.  Molecular profiling of hepatocellular carcinomas by cDNA microarray.

Authors:  Lian-Hai Zhang; Jia-Fu Ji
Journal:  World J Gastroenterol       Date:  2005-01-28       Impact factor: 5.742

7.  Promotion of liver cancer development by brief exposure to dietary 2-acetylaminofluorene plus partial hepatectomy or carbon tetrachloride.

Authors:  D B Solt; E Cayama; H Tsuda; K Enomoto; G Lee; E Farber
Journal:  Cancer Res       Date:  1983-01       Impact factor: 12.701

8.  Quantitative stereological evaluation of four histochemical markers of altered foci in multistage hepatocarcinogenesis in the rat.

Authors:  S Hendrich; H A Campbell; H C Pitot
Journal:  Carcinogenesis       Date:  1987-09       Impact factor: 4.944

Review 9.  Regulatory mechanism of glutathione S-transferase P-form during chemical hepatocarcinogenesis: old wine in a new bottle.

Authors:  Ken Higashi; Hiroshi Hiai; Taneaki Higashi; Masami Muramatsu
Journal:  Cancer Lett       Date:  2004-06-25       Impact factor: 8.679

10.  Reduction of liver glutathione peroxidase activity and deficiency of serum selenium in patients with hepatocellular carcinoma.

Authors:  R Corrocher; M Casaril; G Bellisola; G Gabrielli; M Hulpe; E Garofoli; N Nicoli
Journal:  Tumori       Date:  1986-12-31
View more
  10 in total

1.  An expression signature of phenotypic resistance to hepatocellular carcinoma identified by cross-species gene expression analysis.

Authors:  Maddalena Frau; Maria M Simile; Maria L Tomasi; Maria I Demartis; Lucia Daino; Maria A Seddaiu; Stefania Brozzetti; Claudio F Feo; Giovanni Massarelli; Giuliana Solinas; Francesco Feo; Ju-Seog Lee; Rosa M Pascale
Journal:  Cell Oncol (Dordr)       Date:  2012-03-21       Impact factor: 6.730

2.  An approach to the study of gene expression in hepatocarcinogenesis initiation.

Authors:  Olga Beltràn-Ramírez; Sergueï Sokol; Véronique Le-Berre; Jean M François; Saúl Villa-Treviño
Journal:  Transl Oncol       Date:  2010-04       Impact factor: 4.243

3.  Analysis of gene expression profiles as a tool to uncover tumor markers of liver cancer progression in a rat model.

Authors:  Verónica R Vásquez-Garzón; Olga Beltrán-Ramírez; Martha E Salcido-Neyoy; Nancy Cervante-Anaya; Saúl Villa-Treviño
Journal:  Biomed Rep       Date:  2014-12-22

4.  MCLR-elicited hepatic fibrosis and carcinogenic gene expression changes persist in rats with diet-induced nonalcoholic steatohepatitis through a 4-week recovery period.

Authors:  Tarana Arman; J Allen Baron; Katherine D Lynch; Laura A White; Johnny Aldan; John D Clarke
Journal:  Toxicology       Date:  2021-11-02       Impact factor: 4.221

5.  Anti-proliferative effect of extremely low frequency electromagnetic field on preneoplastic lesions formation in the rat liver.

Authors:  Mónica Noemí Jiménez-García; Jaime Arellanes-Robledo; Diana Ivette Aparicio-Bautista; Miguel Angel Rodríguez-Segura; Saúl Villa-Treviño; Juan José Godina-Nava
Journal:  BMC Cancer       Date:  2010-04-24       Impact factor: 4.430

6.  Integrative and comparative genomics analysis of early hepatocellular carcinoma differentiated from liver regeneration in young and old.

Authors:  Dilek Colak; Muhammad A Chishti; Al-Bandary Al-Bakheet; Ahmed Al-Qahtani; Mohamed M Shoukri; Malcolm H Goyns; Pinar T Ozand; John Quackenbush; Ben H Park; Namik Kaya
Journal:  Mol Cancer       Date:  2010-06-12       Impact factor: 27.401

7.  Neoplasia: the second decade.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

8.  Induction of cell proliferation in old rat liver can reset certain gene expression levels characteristic of old liver to those associated with young liver.

Authors:  Muhammad A Chishti; Namik Kaya; Al-Bandary Binbakheet; Falah Al-Mohanna; Malcolm H Goyns; Dilek Colak
Journal:  Age (Dordr)       Date:  2012-04-04

9.  Co-Expression of Ezrin-CLIC5-Podocalyxin Is Associated with Migration and Invasiveness in Hepatocellular Carcinoma.

Authors:  Teresita N J Flores-Téllez; Tania V Lopez; Verónica Rocío Vásquez Garzón; Saúl Villa-Treviño
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

10.  Integration of chronological omics data reveals mitochondrial regulatory mechanisms during the development of hepatocellular carcinoma.

Authors:  J Noé García-Chávez; Verónica R Vásquez-Garzón; Mercedes G López; Saúl Villa-Treviño; Rafael Montiel
Journal:  PLoS One       Date:  2021-08-12       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.